4.8 Article

Manganese Coordination Micelles That Activate Stimulator of Interferon Genes and Capture In Situ Tumor Antigens for Cancer Metalloimmunotherapy

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Engineering Radiosensitizer-Based Metal-Phenolic Networks Potentiate STING Pathway Activation for Advanced Radiotherapy

Jie Yan et al.

Summary: This paper proposes a strategy combining radiosensitization and STING pathway activation by fabricating a novel radiosensitizer that releases drugs in a pH-responsive manner. This strategy increases the sensitivity of cancer cells to radiation therapy and promotes immune response, improving the efficacy of cancer radiotherapy.

ADVANCED MATERIALS (2022)

Review Chemistry, Inorganic & Nuclear

Metal-based nano-vaccines for cancer immunotherapy

Jiexin Li et al.

Summary: Metalloimmunology has the potential to revitalize cancer vaccines by utilizing metal-based nanomaterials as adjuvants or delivery carriers to enhance immunity and improve the induction of antigen specific T cells for cancer immunotherapy.

COORDINATION CHEMISTRY REVIEWS (2022)

Article Chemistry, Multidisciplinary

Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy

Hao Tian et al.

Summary: A phenolic nanoadjuvant has been developed to enhance the maturation of dendritic cells (DCs) and improve the efficacy of cancer immunotherapy. This nanoadjuvant promotes the activation of the cGAS-STING pathway and sensitizes tumors to PD-L1 checkpoint blockade immunotherapy, resulting in inhibiting tumor growth and restraining lung metastasis.

NANO TODAY (2022)

Article Chemistry, Physical

Magnetic Metal Micelles for Enhanced Delivery of Self-Immolating CD8+ T-Cell Epitopes for Cancer Immunotherapy

Jiexin Li et al.

Summary: A self-assembled magnetic micelle delivery system was developed for targeted delivery of CD8(+) T-cell epitopes, producing strong cellular immune responses. Metal ions enhanced vaccine immunogenicity, while a self-immolative linker allowed for rapid antigen release. The system eradicated tumors in a mouse model, demonstrating potential for developing a new generation of cancer vaccines with multiple functionalities.

CHEMISTRY OF MATERIALS (2021)

Article Engineering, Biomedical

Self-Adjuvanted Molecular Activator (SeaMac) Nanovaccines Promote Cancer Immunotherapy

Zichao Luo et al.

Summary: Neoantigen-based immunotherapy, while promising, faces limitations such as impotent neoantigens, high costs, and complications from adjuvants. Self-adjuvanted nanovaccines designed for in vivo neoantigen-harvesting demonstrate significant inhibition of tumor growth and promote immune cell expansion in tumor models, without the need for adjuvants or immune checkpoint inhibitors. These nanovaccines, when combined with an anti-PD-L1 antibody, can evoke robust, long-term memory immune responses, showing potential as a simple, safe, and affordable approach to boost cancer immunotherapy.

ADVANCED HEALTHCARE MATERIALS (2021)

Article Chemistry, Multidisciplinary

Injectable Adhesive Hydrogel as Photothermal-Derived Antigen Reservoir for Enhanced Anti-Tumor Immune

Man Fan et al.

Summary: The study presents a novel injectable adhesive hydrogel loaded with MnO2 nanoparticles that induce immunogenic cell death and release tumor protein antigens to stimulate the immune response, effectively inhibiting tumor growth.

ADVANCED FUNCTIONAL MATERIALS (2021)

Review Oncology

Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity

Yong Liang et al.

Summary: Immune checkpoint inhibitors are successful immunotherapy modalities that enhance CD8(+) T-cell responses. Recent studies have found that cross-priming of conventional type 1 dendritic cells (cDC1) plays a crucial role in initiating CD8(+) T-cell responses during tumor progression, as well as in immunotherapy-mediated reactivation of tumor-specific CD8(+) T cells for tumor regression. Inducing type I IFNs within tumors can overcome innate immune resistance and activate antitumor adaptive immunity.

CLINICAL CANCER RESEARCH (2021)

Article Nanoscience & Nanotechnology

Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy

Xiaoqi Sun et al.

Summary: Metalloimmunotherapy utilizes metal ions to amplify the anti-tumour immune response promoted by STING agonists, forming nanoparticles that effectively deliver STING agonists and achieve remarkable therapeutic efficacy in multiple tumour models. This work highlights the great potential of coordination nanomedicine for metalloimmunotherapy.

NATURE NANOTECHNOLOGY (2021)

Article Multidisciplinary Sciences

Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer

Yuyan Jiang et al.

Summary: The authors present a strategy for controlled immune regulation in cancer nano-immunotherapy using a photothermally activatable semiconducting polymeric pro-agonist responsive to second near-infrared window light.

NATURE COMMUNICATIONS (2021)

Article Immunology

Manganese salts function as potent adjuvants

Rui Zhang et al.

Summary: The colloidal manganese salt (Mn jelly, MnJ) acts as both an immune potentiator and a delivery system, promoting immune responses by inducing antibody production and CD4(+)/CD8(+) T-cell proliferation and activation. It also shows promise as a mucosal adjuvant, inducing high levels of secretory IgA and proving effective for various antigens, making it a potential candidate for adjuvant use.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Cell Biology

The STING phase-separator suppresses innate immune signalling

Xiaoyu Yu et al.

Summary: Yu et al. discovered that STING biomolecular condensates can form in virus-infected cells, leading to the restriction of TBK1 activation and innate immunity responses. The study revealed the presence of a unique STING phase-separator in the ER membrane, which plays a crucial role in regulating innate immune signaling pathways.

NATURE CELL BIOLOGY (2021)

Article Immunology

A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection

Fiachra Humphries et al.

Summary: This study describes a compound, diABZI-4, that activates stimulator of interferon genes (STING) and effectively limits SARS-CoV-2 replication in cells and animals. The administration of diABZI-4 intranasally in mice provided complete protection from severe respiratory disease caused by SARS-CoV-2. It induces a rapid, short-lived activation of STING, leading to transient proinflammatory cytokine production and lymphocyte activation in the lung, ultimately inhibiting viral replication. The study supports the use of diABZI-4 as a host-directed therapy for the treatment and prevention of COVID-19.

SCIENCE IMMUNOLOGY (2021)

Article Chemistry, Multidisciplinary

Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus

Yaling Wang et al.

Summary: The new nanovaccine containing RBD and MnARK shows stronger neutralizing abilities against infection compared to the Alum-adsorbed RBD vaccine. The co-delivery of RBD antigen and MnARK to lymph nodes promotes cellular internalization and the activation of immune cells.

NANO TODAY (2021)

Article Pharmacology & Pharmacy

A Manganese Phosphate Nanocluster Activates the cGAS-STING Pathway for Enhanced Cancer Immunotherapy

Min Gao et al.

Summary: The newly developed MnP-PEG nanoclusters with high biocompatibility can activate immature bone marrow-derived dendritic cells, leading to significantly higher production of interferon beta and interleukin-6. This potent STING activation capacity is likely due to the efficient cellular internalization of MnP-PEG nanoclusters by dendritic cells and acid-triggered release of Mn2+ ions in endolysosomes.

ADVANCED THERAPEUTICS (2021)

Article Chemistry, Multidisciplinary

Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy

Hongzhang Deng et al.

NANO LETTERS (2020)

Review Oncology

The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer

John Kwon et al.

CANCER DISCOVERY (2020)

Article Immunology

NK cells mediate clearance of CD8(+) T cell-resistant tumors in response to STING agonists

Christopher J. Nicolai et al.

SCIENCE IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death

Hongzhang Deng et al.

NATURE COMMUNICATIONS (2020)

Review Immunology

STING pathway agonism as a cancer therapeutic

Blake A. Flood et al.

IMMUNOLOGICAL REVIEWS (2019)

Article Medicine, Research & Experimental

Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation

Jianzhou Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Biochemistry & Molecular Biology

A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

Miguel F. Sanmamed et al.

Article Multidisciplinary Sciences

Design of amidobenzimidazole STING receptor agonists with systemic activity

Joshi M. Ramanjulu et al.

NATURE (2018)

Article Multidisciplinary Sciences

Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1

Kazuki Kato et al.

NATURE COMMUNICATIONS (2018)

Review Oncology

Extracellular ATP and P2 purinergic signalling in the tumour microenvironment

Francesco Di Virgilio et al.

NATURE REVIEWS CANCER (2018)

Review Oncology

De-novo and acquired resistance to immune checkpoint targeting

Nicholas L. Syn et al.

LANCET ONCOLOGY (2017)

Article Multidisciplinary Sciences

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response

Alexander C. Huang et al.

NATURE (2017)

Article Nanoscience & Nanotechnology

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

Yuanzeng Min et al.

NATURE NANOTECHNOLOGY (2017)

Article Biochemistry & Molecular Biology

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan et al.

Review Immunology

Immunogenic cell death in cancer and infectious disease

Lorenzo Galluzzi et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Review Immunology

The urgent need to recover MHC class I in cancers for effective immunotherapy

Federico Garrido et al.

CURRENT OPINION IN IMMUNOLOGY (2016)

Article Medicine, General & Internal

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

Antoni Ribas et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Review Nutrition & Dietetics

Manganese Is Essential for Neuronal Health

Kyle J. Horning et al.

ANNUAL REVIEW OF NUTRITION, VOL 35 (2015)

Review Environmental Sciences

Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features

Gunnar F. Kwakye et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2015)

Article Biochemistry & Molecular Biology

Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs

Lingyin Li et al.

NATURE CHEMICAL BIOLOGY (2014)

Article Biochemistry & Molecular Biology

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu et al.

NATURE MEDICINE (2014)

Article Nanoscience & Nanotechnology

Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines

Yumiao Zhang et al.

NATURE NANOTECHNOLOGY (2014)

Review Immunology

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen et al.

IMMUNITY (2013)

Editorial Material Multidisciplinary Sciences

Cancer Immunotherapy

Marcia McNutt

SCIENCE (2013)

Review Immunology

Type I interferon response and innate immune sensing of cancer

Mercedes B. Fuertes et al.

TRENDS IN IMMUNOLOGY (2013)

Review Oncology

Dendritic Cells in the Cancer Microenvironment

Yang Ma et al.

JOURNAL OF CANCER (2013)

Review Multidisciplinary Sciences

Innate or Adaptive Immunity? The Example of Natural Killer Cells

Eric Vivier et al.

SCIENCE (2011)

Review Multidisciplinary Sciences

Metalloproteins and metal sensing

Kevin J. Waldron et al.

NATURE (2009)

Article Immunology

Type I IFN contributes to NK cell homeostasis, activation, and antitumor function

Jeremy B. Swann et al.

JOURNAL OF IMMUNOLOGY (2007)